NDA 20-358

Page 3

 

If you have any questions concerning this NDA, please contact Mr. Paul David, Project Manager, at (301) 594-5530.

 

 

Sincerely yours,

 

(Signature 10/2/96)

Robert Temple, M.D.

Director

Office of Drug Evaluation I

Center for Drug Evaluation and Research

 

Back a Page
Next Page
Back to Wellbutrin SR® NDA Index Page
Back to Main Index